Prevalence of Genes Encoding Aminoglycoside-Modifying Enzymes and armA among Acinetobacter baumannii Clinical Isolates in Alexandria, Egypt.

ELsheredy, Amel; Yousif, Zainab; Elghazzawi, Ebtesam; Elmenshawy, Ahmed; Ghazal, Abeer

ELsheredy, Amel; Yousif, Zainab; Elghazzawi, Ebtesam; Elmenshawy, Ahmed; Ghazal, Abeer.

Afiliación

ELsheredy A; Microbiology Department, Medical Research Institute, Alexandria University, Alexandria,Egypt.
Yousif Z; Basic Science Department, Faculty of Dentistry, Al Anbar University, Al Anbar,Iraq.
Elghazzawi E; Microbiology Department, Medical Research Institute, Alexandria University, Alexandria,Egypt.
Elmenshawy A; Critical Care Medicine Department, Faculty of Medicine, Alexandria University, Alexandria,Egypt.
Ghazal A; Microbiology Department, Medical Research Institute, Alexandria University, Alexandria,Egypt.

Infect Disord Drug Targets ; 21(8): e300821191828, 2021.

Article en En | MEDLINE | ID: mdl-33632111

Asunto(s)

Acinetobacter baumannii; Acinetobacter baumannii/genética; Aminoglicósidos/farmacología; Antibacterianos/farmacología; Proteínas Bacterianas/genética; Farmacorresistencia Bacteriana Múltiple/genética; Egipto/epidemiología; Humanos; Pruebas de Sensibilidad Microbiana; Prevalencia; beta-Lactamasas/genética; beta-Lactamasas/farmacología

Palabras clave

Acinetobacter baumannii; aminoglycosides.; intensive care unit; multidrug resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acinetobacter baumannii Tipo de estudio: Prevalence_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: Infect Disord Drug Targets Asunto de la revista: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google